Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid

J Eur Acad Dermatol Venereol. 2024 Aug;38(8):e722-e728. doi: 10.1111/jdv.19860. Epub 2024 Feb 24.

N Kramer¹, G Müller¹, S Zierold¹, M Röckel², W Fröhlich², M Schefzyk³, J Kumbrink⁴, J C Hassel⁵, C Berking², M Ziemer⁶, D Nashan⁷, L E French^{1

8}, J Vera², K E Kerl-French¹, R Gutzmer⁹, L Heinzerling^{1

2}

¹ Department of Dermatology and Allergology, University Hospital, LMU Munich, Munich, Germany.
² Department of Dermatology, Uniklinikum Erlangen, Comprehensive Cancer Center Erlangen - EMN, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
³ Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
⁴ Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.
⁵ Department of Dermatology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.
⁶ Department of Dermatology, Allergology and Venerology, University Medical Center, Leipzig, Germany.
⁷ Department of Dermatology, Hospital Dortmund, Dortmund, Germany.
⁸ Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida, USA.
⁹ Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum Campus Minden, Minden, Germany.

No abstract available

Publication types